US Bancorp
RGNX icon

US Bancorp’s Regenxbio RGNX Stock Holding History

US Bancorp’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.3K Sell
2,178
-476
-18% -$5K ﹤0.01% 3157
2025
Q4 		$38.2K Hold
2,654
– – ﹤0.01% 2815
2025
Q3 		$25.6K Sell
2,654
-22
-0.8% -$195 ﹤0.01% 2973
2025
Q2 		$22K Buy
2,676
+179
+7% +$1.5K ﹤0.01% 3139
2025
Q1 		$17.9K Buy
2,497
+2,367
+1,821% +$17.6K ﹤0.01% 3223
2024
Q4 		$1K Sell
130
-2,352
-95% -$22.1K ﹤0.01% 3954
2024
Q3 		$26K Sell
2,482
-1,789
-42% -$21.8K ﹤0.01% 3034
2024
Q2 		$50K Sell
4,271
-2,151
-33% -$33.5K ﹤0.01% 2678
2024
Q1 		$135K Sell
6,422
-7,409
-54% -$132K ﹤0.01% 2211
2023
Q4 		$248K Buy
13,831
+13,586
+5,545% +$239K ﹤0.01% 1903
2023
Q3 		$4.03K Hold
245
– – ﹤0.01% 3497
2023
Q2 		$4.9K Buy
245
+37
+18% +$713 ﹤0.01% 3486
2023
Q1 		$3.93K Sell
208
-23
-10% -$509 ﹤0.01% 3602
2022
Q4 		$5.24K Sell
231
-62
-21% -$1.4K ﹤0.01% 3493
2022
Q3 		$8K Sell
293
-214
-42% -$6.35K ﹤0.01% 3454
2022
Q2 		$13K Sell
507
-419
-45% -$10.5K ﹤0.01% 3281
2022
Q1 		$31K Buy
926
+142
+18% +$3.94K ﹤0.01% 2840
2021
Q4 		$26K Buy
784
+154
+24% +$5.24K ﹤0.01% 2977
2021
Q3 		$26K Buy
630
+227
+56% +$8.17K ﹤0.01% 2995
2021
Q2 		$16K Buy
403
+218
+118% +$7.8K ﹤0.01% 3248
2021
Q1 		$6K Hold
185
– – ﹤0.01% 3461
2020
Q4 		$8K Buy
+185
New +$6.46K ﹤0.01% 3267
2020
Q1 		– Sell
-39
Closed -$2K – 3772
2019
Q4 		$2K Hold
39
– – ﹤0.01% 3497
2019
Q3 		$1K Sell
39
-15
-28% -$608 ﹤0.01% 3512
2019
Q2 		$3K Hold
54
– – ﹤0.01% 3397
2019
Q1 		$3K Hold
54
– – ﹤0.01% 3360
2018
Q4 		$2K Buy
54
+18
+50% +$1.06K ﹤0.01% 3427
2018
Q3 		$3K Buy
+36
New +$2.59K ﹤0.01% 3434

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

US Bancorp's RGNX Position: Q1 2026 in Review

US Bancorp reduced its Regenxbio (RGNX) stake by 18% in Q1 2026, selling an estimated $5K and leaving 2,178 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3157.

US Bancorp first reported a position in RGNX in Q3 2018 and has held it in 28 quarters since. The position peaked at $248K in Q4 2023. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • US Bancorp held 2,178 shares of Regenxbio worth $18.3K as of Q1 2026.
  • US Bancorp sold 476 Regenxbio shares in Q1 2026, an estimated $5K.
  • Regenxbio made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3157 holding.
  • US Bancorp first reported a position in Regenxbio in Q3 2018 and has held it in 28 quarters since.
  • US Bancorp's Regenxbio position peaked at $248K in Q4 2023.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.